Results for tag: "Blosozumab"

Blosozumab is a monoclonal antibody used to treat musculoskeletal disorders. It is a type of biologic drug, meaning it is made from living cells and is designed to target specific molecules in the body. Blosozumab works by blocking the action of a protein called sclerostin, which is involved in the development of bone and muscle disorders. By blocking sclerostin, blosozumab can help reduce the symptoms of musculoskeletal disorders, such as pain, stiffness, and swelling. Blosozumab is approved for use in the United States and Europe, and is currently being studied in clinical trials for other indications. It is available in both intravenous and subcutaneous formulations. The blosozumab market is a rapidly growing segment of the musculoskeletal disorders drugs market. It is expected to continue to grow as more clinical trials are conducted and more indications are approved. Some companies in the blosozumab market include Amgen, Eli Lilly, and Pfizer. Show Less Read more